DrugJan 24, 2024
SECRET ANTIPERSPIRANT Secret, powder fresh recall — FDA D-0253-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
Latest records
Latest recalls — page 256
The newest recall records with useful source details are listed here.
DrugJan 24, 2024
The Procter & Gamble Company Old Spice, SWEAT DEFENSE PURE SPORT PLUS recall — FDA D-0251-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
The Procter & Gamble Company Old Spice, SWEAT DEFENSE ULTIMATE CAPTAIN, Aluminum recall — FDA D-0252-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
The Procter & Gamble Company Secret, OUTLAST, Dry Spray recall — FDA D-0247-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
SECRET ANTIPERSPIRANT Secret, powder fresh, Aluminum chlorohydrate 24% recall — FDA D-0242-2024
Chemical contamination: presence of benzene
Class IFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
The Procter & Gamble Company Old Spice Pure Sport 2021 Gift Set, Contains: Old Spice Pure recall — FDA D-0249-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
Pfizer 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit recall — FDA D-0233-2024
Presence of Particulate Matter; identified as glass
Class IFDA: OngoingPfizer Inc.
DrugJan 24, 2024
The Procter & Gamble Company Secret OUTLAST Dry Spray recall — FDA D-0248-2024
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Class IIFDA: TerminatedThe Procter & Gamble Company
DrugJan 24, 2024
MAGNESIUM CITRATE Good Neighbor Pharmacy, DYE FREE, SUGAR FREE Magnesium Citrate Saline recall — FDA D-0227-2024
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Class IIFDA: OngoingPharma Nobis LLC
VehicleJan 22, 2024
Tesla camera recall — NHTSA campaign 24V035000
Tesla, Inc. (Tesla) is recalling certain 2023 Model S, X, and Y vehicles equipped with full self-driving computer 4.0 and running a software release version 2023.44.30 through 2023.44.30.6…
cameraTesla, Inc.
VehicleJan 19, 2024
Explorer roof and pillars recall — NHTSA campaign 24V031000
Ford Motor Company (Ford) is recalling certain 2011-2019 Explorer vehicles. The A-pillar trim retention clips may not be properly engaged, allowing the trim to detach.
roof and pillarsFord Motor Company
VehicleJan 18, 2024
Kia roof and pillars recall — NHTSA campaign 24V025000
Kia America, Inc. (Kia) is recalling certain 2023-2024 Sportage and 2022-2024 Carnival vehicles. The roof molding may loosen and detach.
roof and pillarsKia America, Inc.
DrugJan 17, 2024
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles recall — FDA D-0222-2024
Presence of Foreign Tablets/Capsules
Class IIFDA: OngoingRising Pharma Holding, Inc.
DrugJan 17, 2024
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box recall — FDA D-0220-2024
Defective Container: powder may leak out of the pouch
Class IFDA: CompletedInvaGen Pharmaceuticals, Inc.
VehicleJan 10, 2024
XC40 electrical system software recall — NHTSA campaign 24V010000
Volvo Car USA, LLC (Volvo Car) is recalling certain 2024 XC40 vehicles. A diagnostic error in the Central Electronic Module (CEM) software may cause the left rear turn signal indicator to…
electrical system softwareVolvo Car USA, LLC
DrugJan 10, 2024
Seaway Pharma Premier Value Tussin Cough DM, Dextromethorphan HBr...Cough Suppressant recall — FDA D-0215-2024
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Class IIFDA: OngoingSeaway Pharma Inc.
DrugJan 10, 2024
OXYMETAZOLINE HYDROCHLORIDE Quality Choice No Drip Severe Congestion Nasal Pump Mist recall — FDA D-0217-2024
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Class IIFDA: OngoingSeaway Pharma Inc.
DrugJan 10, 2024
OXYMETAZOLINE HYDROCHLORIDE Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution recall — FDA D-0214-2024
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Class IIFDA: OngoingSeaway Pharma Inc.
DrugJan 10, 2024
OXYMETAZOLINE HYDROCHLORIDE Quality Choice No Drip Extra Moisturizing Nasal Pump Mist recall — FDA D-0216-2024
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Class IIFDA: OngoingSeaway Pharma Inc.
DrugJan 3, 2024
ALBUTEROL SULFATE HFA Inhalation Aerosol, 90MCG per actuation, 200 Metered Inhalations, Net recall — FDA D-0162-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class IIFDA: TerminatedCARDINAL HEALTHCARE
DrugJan 3, 2024
ALBUTEROL SULFATE IN 90MCG per actuation, 200 Metered Inhalations recall — FDA D-0163-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class IIFDA: TerminatedCARDINAL HEALTHCARE
DrugJan 3, 2024
Jardiance (empagliflozin tablets), 25 mg, 30 tablets recall — FDA D-0185-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class IIFDA: TerminatedCARDINAL HEALTHCARE
DrugJan 3, 2024
Asmanex Twisthaler recall — FDA D-0169-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class IIFDA: TerminatedCARDINAL HEALTHCARE
DrugJan 3, 2024
CHLORTHALIDONE Tablets, USP, 25MG, 1000 Tablets recall — FDA D-0172-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class IIFDA: TerminatedCARDINAL HEALTHCARE
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories